Skip to main content
The Maple Markets

Canadian Securities Exchange (CSE) · GTTX.CN · ISIN CA37187D1087

GeneTether Therapeutics Inc.

No trading activity has been reported for this listing since January 7, 2025. It may be delisted, halted or inactive.

0.1200 CAD

January 7, 2025

Sign in to add to portfolio

GeneTether Therapeutics Inc. (GTTX.CN) trades on the Canadian Securities Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 4.65M CAD. Its ISIN is CA37187D1087. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Key facts

Exchange

Canadian Securities Exchange (CSE)

ISIN

CA37187D1087

Sector

Healthcare

Industry

Biotechnology

Country

CA

Market cap

4.65M CAD

Previous close

0.12 CAD

Day range

0.12 – 0.12

52-week range

0.12 – 0.12

Volume

0

50-day average

0.07 CAD

200-day average

0.05 CAD

Asset type

Equity

About GeneTether Therapeutics Inc.

GeneTether Therapeutics Inc. (GTTX.CN) is a biotechnology firm specializing in genetic medicines. Its primary focus is the advancement of gene-editing therapies, aiming to significantly boost the effectiveness of current genomic modification techniques. The company's pipeline is dedicated to engineering genetic treatments for individuals suffering from rare, single-gene disorders affecting the kidneys and skin. Established in 2018, GeneTether Therapeutics Inc. is headquartered in Kelowna, Canada.

Company website

Frequently asked

+
What is the GTTX.CN share price today?
This page shows the latest available GeneTether Therapeutics Inc. (GTTX.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is GeneTether Therapeutics Inc. listed?
GeneTether Therapeutics Inc. trades on the Canadian Securities Exchange under the symbol GTTX.CN, ISIN CA37187D1087.
+
How large is GeneTether Therapeutics Inc.?
Its market capitalisation is approximately 4.65M CAD, based on the latest available price and share count from our data provider.

All GeneTether Therapeutics Inc. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy